CBD Innovative Drugs
In 2020, DMD’s UltraSpec Lab creatively applied AI (Artificial Intelligence) to drug development and used this technology to provide an optimized pathway for drug development and to obtain accurate drug formulations.
On October 17, 2018, Canada federally legalized cannabis. Currently, cannabis has medical effects that are recognized by most countries around the world. Our self-developed artificial intelligence cellular-level human organ metabolism simulator can effectively simulate the metabolic performance of different drug components in cells within different organs of the human body, and we have used this simulator and accurate target algorithm as a tool to complete four innovative drugs with industrial cannabidiol (CBD) as the main ingredient.
CBD adjuvant cancer drugs
Relief of nausea and vomiting caused by radiotherapy for various cancers.
CBD topical anti-inflammatory drugs
Relieve various topical inflammation, such as arthritis, etc.
CBD chronic pain medication
Relief of various chronic pains.
CBD tranquilizer antidepressant
Antidepressant, calming and improves sleep quality.
Introducing
Nano Microneedle Patch
How to use
Apply to skin surface (once a week)
Key Features
- Utilizing natural plant hemp extract CBD (cannabidiol) as the major ingredient
- Exclusive Technology from Canada
- Simulation of human experiment with AI technology
- Non-regulated ingredients
- Nanoscale material
- Topical patch
- Long-term slow-release dosage form
- Decrease taking drugs frequently
- Significant effect
- Non-addictive
